김남희

진료분야

담낭용종, 담석증, 담도암, 담낭암, 담도폐쇄, 췌장낭종, 췌장암, 췌장염, 치료내시경

진료일정

  • 외래진료
  • 국내 학회
  • 국외 학회
  • 강의
  • 휴가
  • 기타
구분 월 화 수 목 금 토
오전
오후
온라인 진료예약 바로가기

학력 및 경력

2004-2010 조선대학교 의과대학 졸업
2010-2011 성균관의대 강북삼성병원 인턴
2011-2015 성균관의대 강북삼성병원 내과 전공의
2015-2017 성균관의대 강북삼성병원 소화기내과 임상강사
2016-2018 성균관의대 대학원 내과학 석사 
2017-2020 성균관의대 강북삼성병원 예방건진센터 소화기 내시경파트 임상조교수
2018-2020 성균관의대 대학원 내과학 박사
2020-        성균관의대 강북삼성병원 소화기내과 임상조교수

학회 활동

[학회활동]
The Korean Society of Pancreatobiliary Diseases 
The Korean Society of Gastrointestional Cancer 
The Korean Society of Gastrointestinal Endoscopy 
The Korean Association for the Study of Intestinal Diseases
The Korean Medical Association 
The Korean Society of Gastroenterology 
The Korean Association for the Study of the Liver 
The Korean Liver Cancer Study Group

[수상경력]
강북삼성병원 2019 젊은 연구자상
강북삼성병원 2018 우수 연구 스탭상 
Taiwan Digestive Disease Week 2019, Rising star 선정 
대한장연구학회 최다논문 인용 공로상 (2017, 2018, 2019년)
대한장연구학회 IMKASID 2018, Young Investigator Award 
Asian Pacific Digestive Week 2017, Young Investigator Award 
대한장연구학회 2015 패링학술상 
대한소화기학회 2015 추계 소화기연관학회, 최우수 연제상

대표 논문

1.Risk of developing metachronous advanced colorectal neoplasia after resection of low-risk diminutive versus small adenomas.
Kim NH, Jung YS, Park JH, Park DI, Sohn CI.
Gastrointest Endosc. 2020 Mar;91(3):622-630.

2. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization.
Kim NH, Kim HJ, Cho YK, Hong HP, Kim BI.
J Korean Med Sci. 2019 Aug 5;34(30):e208

3. Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas.
Kim NH, Jung YS, Lee MY, Park JH, Park DI, Sohn CI.
Am J Gastroenterol. 2019 Oct;114(10):1657-1664.

4. Impact of obesity and metabolic abnormalities on the risk of metachronous colorectal neoplasia after polypectomy in men.
Kim NH, Jung YS, Park JH, Park DI, Sohn CI.
J Gastroenterol Hepatol. 2019 Sep;34(9):1504-1510

5. Long-term efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study.
Kim NH, Lee JH, Hong SN, Yoon H, Kang HW, Lee SH, Im JP, Cha JM, Eun CS, Kim JW, Choi CH, Park DI.
J Gastroenterol Hepatol. 2019 Sep;34(9):1523-1532.

6. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH, Lim JW, Kim S, Lim JY, Kim W, Park JH, Park DI, Sohn CI, Jung YS.
Dig Liver Dis. 2019 Apr;51(4):589-594.

7. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy.
Kim NH, Jung YS, Lim JW, Park JH, Park DI, Sohn CI.
Gastrointest Endosc. 2019 May;89(5):1037-1043.

8. Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged < 50 years.
Kim NH, Jung YS, Park JH, Park DI, Sohn CI.
J Gastroenterol Hepatol. 2019 Feb;34(2):383-389.

9. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH, Kim HJ.
Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):450-455.

10. Influence of Obesity and Metabolic Abnormalities on the Risk of Developing Colorectal Neoplasia.
Kim NH, Jung YS, Park JH, Park DI, Sohn CI.
Dig Dis Sci. 2018 Nov;63(11):3126-3133.

11. Prevalence of and Risk Factors for Colorectal Neoplasia in Asymptomatic Young Adults (20-39 Years Old).
Kim NH, Jung YS, Yang HJ, Park SK, Park JH, Park DI, Sohn CI.
Clin Gastroenterol Hepatol. 2019 Jan;17(1):115-122.

12. Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment.
Kim NH, Cho YK, Kim BI, Kim HJ.
Dig Dis Sci. 2018 Oct;63(10):2792-2799.

13. Abdominal Obesity is More Predictive of Advanced Colorectal Neoplasia Risk Than Overall Obesity in Men: A Cross-sectional Study.
Kim NH, Jung YS, Park JH, Park DI, Sohn CI.
J Clin Gastroenterol. 2019 Aug;53(7):e284-e290.

14. Risk of developing metachronous advanced colorectal neoplasia after colonoscopic polypectomy in patients aged 30 to 39 and 40 to 49 years.
Kim NH, Jung YS, Park JH, Park DI, Sohn CI.
Gastrointest Endosc. 2018 Oct;88(4):715-723.

15. Age at menarche and risk of colorectal adenoma.
Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Korean J Intern Med. 2019 Sep;34(5):998-1007.

16. Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease.
Kim NH, Jung YS, Hong HP, Park JH, Kim HJ, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.
Liver Int. 2018 Aug;38(8):1487-1494.

17. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
Kim NH, Park CH, Park JH, Park DI, Sohn CI, Jung YS.
Gastrointest Endosc. 2018 Jul;88(1):128-135.

18. Association Between Cotinine-verified Smoking Status and Risk of Colorectal Neoplasia.
Kim NH, Jung YS, Yang HJ, Park SK, Park JH, Park DI, Sohn CI.
J Clin Gastroenterol. 2019 Mar;53(3):e107-e112.

19. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
Kim NH, Lee T, Cho YK, Kim BI, Kim HJ.
J Gastroenterol Hepatol. 2018 Jul;33(7):1397-1406.

20. Should asymptomatic young men with iron deficiency anemia necessarily undergo endoscopy?
Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Korean J Intern Med. 2018 Nov;33(6):1084-1092.

21. Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis.
Kim NH, Kim HJ, Bang KB.
Hepatobiliary Pancreat Dis Int. 2017 Oct 15;16(5):512-518.

22. Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
Kim NH, Lee MY, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Yonsei Med J. 2017 Sep;58(5):918-924.

23. A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men.
Kim NH, Lee MY, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Yonsei Med J. 2017 Sep;58(5):910-917.

24. The risk of colorectal neoplasia can be different according to the types of family members affected by colorectal cancer.
Kim NH, Yang HJ, Park SK, Park JH, Park DI, Sohn CI, Jung YS.
J Gastroenterol Hepatol. 2018 Feb;33(2):397-403.

25. Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies.
Kim NH, Jung YS, Jeong WS, Yang HJ, Park SK, Choi K, Park DI.
Intest Res. 2017 Jul;15(3):411-418.

26. Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer?
Kim NH, Park JH, Park DI, Sohn CI, Jung YS.
J Korean Med Sci. 2017 Aug;32(8):1281-1287.

27. Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies.
Kim NH, Suh JY, Park JH, Park DI, Cho YK, Sohn CI, Choi K, Jung YS.
Yonsei Med J. 2017 Mar;58(2):347-354.

28. The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.
Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Dig Liver Dis. 2017 May;49(5):557-561.

29. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Yonsei Med J. 2017 Jan;58(1):150-157.

30. Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy: A single-center experience in Korea.
Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Medicine (Baltimore). 2016 Aug;95(32):e4454.

31. Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening.
Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
J Clin Gastroenterol. 2017 Feb;51(2):151-159.

32. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
Kim NH, Yang HJ, Park SK, Park JH, Park DI, Sohn CI, Choi K, Jung YS.
Dig Dis Sci. 2016 Sep;61(9):2685-93.

33. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia.
Kim NH, Kwon MJ, Kim HY, Lee T, Jeong SH, Park DI, Choi K, Jung YS.
Dig Liver Dis. 2016 Jun;48(6):667-72.

34. Risk of developing advanced colorectal neoplasia after removing high-risk adenoma detected at index colonoscopy in young patients: A KASID study.
Kim NH, Park SK, Jung YS, Kim WH, Eun CS, Ko BM, Seo GS, Cha JM, Park JJ, Kim KO, Moon CM, Jung Y, Kim ES, Jeon SR, Lee CK, Park DI; Intestinal cancer study group of Korean Association for Study of Intestinal Diseases (KASID).
J Gastroenterol Hepatol. 2016 Jan;31(1):138-44.

35. Environmental heavy metal exposure and chronic kidney disease in the general population.
Kim NH, Hyun YY, Lee KB, Chang Y, Ryu S, Oh KH, Ahn C.
J Korean Med Sci. 2015 Mar;30(3):272-7.

36. Long-term clinical outcomes of korean patient with Crohn's disease following early use of infliximab.
Kim NH, Jung YS, Moon CM, Lee SY, Kim ER, Kim YH, Lee CK, Lee SH, Kim JH, Huh KC, Yoon SM, Song HJ, Boo SJ, Jang HJ, Kim YS, Lee KM, Shin JE, Park DI.
Intest Res. 2014 Oct;12(4):281-6.

기타
  • 정보보호관리체계(ISMS) 인증
  • 국제정보보호(ISO27001) 인증
  • 보건복지부
    의료기관 인증병원
  • 생명의학연구윤리 국제인증 획득
  • 美, 하원 표창장
  • 美, 존스홉킨스
    연구협약 체결